Novo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer
US biotech viewed as lucrative target partly because of its promising pipeline of weight-loss drugs Novo Nordisk has launched a surprise $9bn (£6.9bn) offer for the US obesity-focused biotech firm Metsera that could gazump an existing bid from Pfizer as the pharmaceutical giants fight for (…)
Site référencé:
The Guardian
5600.jpg?width=140&quality=85&auto=format&fit=max&s=3c9fbe44095ac082c7d3ab69690c3997, 5600.jpg?width=460&quality=85&auto=format&fit=max&s=cfb59dc39e88893fa40a3c4f100554b7, 5600.jpg?width=700&quality=85&auto=format&fit=max&s=a68123dfb611648b76cc65a9b7551f47
The Guardian
‘Morrisons killed us’ : UK’s most westerly village shop closes after half a century
30/10/2025
Prayers for a Hungry Ghost review – a monster take on family trauma
30/10/2025
No 10 refuses to say if ethics adviser saw proof Reeves’s rental breach was ‘inadvertent’
30/10/2025
Lebanese president orders army to confront Israeli incursions after deadly raid
30/10/2025
Doctor Who lives on ! But who will be the new Time Lord – and is it goodbye to Russell T Davies ?
30/10/2025
How do I break up with a kind and generous man who leaves me feeling cold and irritated ? | Leading questions
30/10/2025